VLRX gained the most today, as it increased 69%. However, it couldn’t hold the gains it made on the day, increasing .86 cents into the close. It recently announced a distribution agreement in New Zealand and Australia with AMSL Diabetes and NZMS Diabetes for the commercialization of its V-Go® Wearable Insulin Delivery device. The past 6 days this stock has been down-trending pretty steeply, however today it gapped up on its biggest volume spike since last November. After that huge morning spike the stock dropped all day long, thanks to it being halted, so because it couldn’t hold its gains I’ll just watch it.

CNET reported earnings today and the stock surged pre-market, from the $2.50’s all the way to the $4.20’s. However, after the market opened this stock just kept down-trending before finally consolidating around the $3.10’s. If this stock is a true earnings winner, then it will be capable of running for the next few days. I’ll keep an eye on it for now.

HMNY was expected to gap up after finishing a few cents higher from its previous close during afterhours and on the heels on the Verizon news. Even though this stock did eventually spike up after the market opened, as many people anticipated (myself included), there was huge panic selling pre-market into the market open that dropped the stock down to the $3.80’s. The time to buy for this one was during that morning panic, as it created a perfect number 5 from Tim’s PennyStocking Framework going from the $3.80’s to a high of $4.83. It also reported earnings today, but I’ll just watch this one for now even though it finished red on the day. Possible re-buy on a morning dip.

VTVT is a biotech stock that gained 40% on Tuesday, however this used to be an $8 stock before dropping to below $1/share. The company announced it had purchased two new properties which signaled they may be expanding, but I don’t think that’s enough of a catalyst to cause the stocks gains. Even though this its down from $8.00, today it had the highest volume of shares traded in the last year, so that tells me a lot of people are interested in this one. This stock moved slowly in the morning then took off into the afternoon, so I’ll keep an eye on this one and look to get in on a morning dip, or near the point where support is established.

EYEG was the winner from my watchlist yesterday, however I was too busy with HMNY and took my eye off this one. The one was a little choppy right at the market open, however afterwards it gradually up-trended all day. It even presented a perfect #5 pattern in the afternoon into the market close. It just announced an $11.25 million public offering which was most likely done to raise cash for them to stay in business. If the afternoon run can continue into the market open then I’m interested.

ARQL spiked up to all-time highs within the last 5 years, and it closed right at resistance. I’m super interested to see if this stock can breakthrough and keep on running. However, will have to play it safe because there’s no clear next resistance level and I don’t want to get caught buying at the top.

I is one I’m still watching as it had a decent morning spike from the $8.30’s all the way to the $9.40’s, before fading back to its morning lows. Even that didn’t stop it as once again this stock provided a great opportunity to dip buy after the morning fade. I missed this great play because I was too focused on HMNY, however I’ll be keeping my eye on this one as its been running the past few days. However, this stock is already up nearly $6 since the beginning of the month, and even though the volume is increasing with it, I’m expecting it to drop very soon. Great short in the future.

NURO, HTGM, CVM, TEUM, TNDM, FRED are other stocks I’m watching for possible plays…NURO announced it would be reporting earnings this Thursday, so I’ll be watching it closely…TNDM again gained some momentum today, however it’s starting to slow down in its run and the volume is starting to fade, as this stock too is up nearly $4 since the end of March. This one is also expected to report earnings on April 26 for the first quarter of 2018.